Clinical Trial Detail

NCT ID NCT02010606
Title Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Cedars-Sinai Medical Center
Indications

glioblastoma multiforme

Therapies

Bevacizumab

Temozolomide

Age Groups: adult

No variant requirements are available.